Molecular Understanding and Pharmacological Potency of Plant-Derived Compounds in Colorectal Cancer (CRC): A Critical Analysis and Future Perspectives

V Mukkavilli, G Ramakrishnan, KR Gujjula… - Cell Biochemistry and …, 2024 - Springer
Colorectal cancer (CRC) is the main driver of fatality and the 3rd most often determined
malignancy. Despite advances in detection and therapy, colorectal cancer (CRC) endures …

Triple Negative Breast Cancer (TNBC): Signalling pathways-Role of plant-based inhibitors

RB Malabadi, MR Sadiya, KP Kolkar… - Open Access Research …, 2024 - oarjbp.com
This review paper highlights and updates the role of plant based inhibitors in controlling the
triple-negative breast cancer (TNBC) via blocking the TNBC signalling pathways. Breast …

Exploring the antitumor potential of novel quinoline derivatives via tubulin polymerization inhibition in breast cancer; design, synthesis and molecular docking

H Abdelmegeed, LMAA Ghany, A Youssef… - RSC …, 2024 - pubs.rsc.org
A series of quinoline derivatives was designed and synthesized as novel tubulin inhibitors
targeting the colchicine binding site. All the rationalized compounds 3a–e, 4a–e, 5a–e, and …

Exploring the potentialities of industrial hemp for sustainable rural development

CF de C Lambert, EA Barbosa Filho… - World Journal of …, 2024 - wjbphs.com
This literature review paper explores the potential sustainable applications of industrial
hemp, contextualizing it within the UN Agenda 2030 Sustainable Development Goals …

[PDF][PDF] Exploring the Role of Phytocannabinoids in Triple Negative Breast Cancer (TNBC) Treatment: A Plant-Derived Medicine Approach

T Røseth - researchgate.net
Abstract Triple Negative Breast Cancer (TNBC) is a highly aggressive and difficult-to-treat
subtype of breast cancer, characterized by the absence of estrogen receptors, progesterone …